Inhibiting GS-FDH to modulate no bioactivity

Details Inhibiting GS-FDH to modulate no bioactivity Inhibiting GS-FDH to modulate no bioactivity

2006-12-29

2009-11-10

Tate, Christopher R. (Department: 1654)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C514S449000

Reexamination Certificate

active

07615535

ABSTRACT:
Patients needing NO donor therapy or inhibition of pathologically proliferating cells or increased NO bioactivity are treated with a therapeutically effective amount of an inhibitor of glutathione-dependent formaldehyde dehydrogenase.

REFERENCES:
patent: 3880995 (1975-04-01), Jones
patent: 4948793 (1990-08-01), Allison et al.
patent: 5444072 (1995-08-01), Patterson et al.
patent: 5648393 (1997-07-01), Stamler et al.
patent: 6057367 (2000-05-01), Stamler et al.
patent: 6150337 (2000-11-01), Tam
patent: 6159500 (2000-12-01), Demopoulos et al.
patent: 6204248 (2001-03-01), Demopoulos et al.
patent: 2001/0012834 (2001-08-01), Stamler
patent: WO 85/00108 (1985-01-01), None
patent: WO 94/01105 (1994-01-01), None
patent: WO 94/12184 (1994-06-01), None
patent: WO 95/22538 (1995-08-01), None
patent: WO 99/64016 (1999-12-01), None
patent: WO 00/37097 (2000-06-01), None
patent: WO 01/00611 (2001-01-01), None
Liu, L., et al., Nature 410, 490-494 (Mar. 22, 2001).
Jensen, D. E., et al., Biochem. J. 331, 659-668 (1998).
Kuwada, M., et al., J. Biochem. 88, 859-869 (1980).

Affiliated with

Also associated with

Rating

Inhibiting GS-FDH to modulate no bioactivity does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Inhibiting GS-FDH to modulate no bioactivity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibiting GS-FDH to modulate no bioactivity will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4080545